Clinical Study of Approved and Investigational Contact Lenses

Completed · Not applicable

Conditions studied: Visual Acuity

In brief

This is a multi-site, 5-visit, double-masked, dispensing study comparing an investigational contact lens with currently-marketed contact lenses. The objective of the study is to evaluate the comfort of the lenses when worn for 30 (-2/+6) days on daily wear modality.

Key facts

Study ID

NCT02708524

Run by

Johnson & Johnson Vision Care, Inc.

People needed

554

Starts

2016-01-01

Expected to finish

2016-03-01

Last updated by the study team

2016-11-09

Who can join

Age: 18 and older, up to 40. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.
• The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
• The subject must be between 18 to 40 years of age at the time of consent.
• The subject's spherical equivalent distance refraction must be in the range of -1.25 to -6.00 in each eye.
• The subject's refractive cylinder must be ≤1.00D in each eye.
• The subject must have best corrected visual acuity of 20/30 or better in each eye.
• The subject must be a habitual frequent replacement (reusable) daily wear spherical silicone hydrogel soft contact lens wearer in both eyes.
• The subject must be able to wear contact lenses for a minimum of 8 hours, 4 days per week.
• The subject must have normal eyes (i.e., no ocular medications or infections of any type).

You may not qualify if…

• Currently pregnant or lactating (subjects who become pregnant during the study will be discontinued).
• Any ocular or systemic allergies or diseases that may interfere with contact lens wear.
• Any systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear.
• Any known sensitive/allergic to Ingredients of OPTI-FREE® PureMoist® solution.
• Any daily disposable, extended wear, monovision, toric or multi-focal contact lens correction.
• Entropion, ectropion, extrusions, chalazia, recurrent styes, glaucoma, history of recurrent corneal erosions, aphakia, or moderate or above corneal distortion.
• Any previous, or planned, ocular or interocular surgery (e.g., radial keratotomy, photorefractive keratectomy (PRK), laser-assisted in situ keratomileusis (LASIK), etc.)
• Any grade 3 or greater slit lamp findings (e.g., edema, corneal neovascularization, corneal staining, tarsal abnormalities, conjunctival injection) on the FDA classification scale, any previous history or signs of a contact lens-related corneal inflammatory event (e.g., past peripheral ulcer or round peripheral scar), or any other ocular abnormality that may contraindicate contact lens wear.
• Any ocular infection.
• Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
• Participation in any contact lens or lens care product clinical trial within 7 days prior to study enrollment.
• History of binocular vision abnormality or strabismus.
• Any infectious disease (e.g., hepatitis, tuberculosis) or a contagious immunosuppressive disease (e.g., HIV), by self-report).
• Employee of investigational clinic (e.g., Investigator, Coordinator, Technician)

Where it is running

• Study site — Montgomery, Alabama, United States
• Study site — Fruit Cove, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Jacksonville, Florida, United States
• Study site — Longwood, Florida, United States
• Study site — Tallahassee, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Roswell, Georgia, United States
• Study site — Bloomington, Illinois, United States
• Study site — East Lansing, Michigan, United States
• Study site — Medina, Minnesota, United States
• Study site — Closter, New Jersey, United States
• Study site — Vestal, New York, United States
• Study site — Granville, Ohio, United States
• Study site — Jacksonville, Texas, United States
• Study site — Salt Lake City, Utah, United States
• Study site — Roanoke, Virginia, United States
• Study site — West Allis, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.